Alemán-Fernández AA, Dorantes-Sánchez M, Castro HJ, González GL, Coto HY, Rodríguez GMA

Language: Spanish
References: 33
Page: 63-69
PDF size: 333.08 Kb.

ABSTRACT

Introduction: There is a growing number of patients with implantable cardioverter-defibrillators. Recurrences are frequent and electrical shocks are the main factor affecting the quality of life.
Objective: To identify the electrocardiographic predictors of the recurrence of malig-nant ventricular arrhythmias in these patients.
Method: From a universe of 76 patients, who had undergone cardioverter-defibrillator implantation, 46 patients were selected and two groups were formed. Group A consisted of 27 patients with at least one episode of malignant ventricular arrhythmias after device implantation; and group B consisted of 19 subjects without recurrences. Measurements (prolonged QTc, abnormal QT dispersion, Tpeak-Tend interval and its abnormal dispersion) were averaged over three consecutive heartbeats in each lead, manually, by two independent observers.
Results: In group A, there was a predominance of structural heart disease and an ejection fraction less than 35%. The fragmentation of the QRS complex, bimodal T wave and early repolarization pattern were also present. There were significant differences in the mean values of the QT interval (428 vs. 390 ms), p=0.004; the corrected QT (476 vs. 436 ms), p=0.011; and Tpeak-Tend interval (108 vs. 87 ms), p=0.006. There were no significant differences in QT dispersion (51 vs. 48 ms), the Tpeak-Tend dispersion (35 vs. 27 ms), or QRS duration (121 vs. 105 ms).
Conclusions: QT, QTc and Tpeak-Tend intervals are electrocardiographic predictors of the recurrence of ventricular arrhythmias in patients with implantable cardioverter-defibrillators.

REFERENCES

1. Moss AJ. QTc prolongation and sudden cardiac death: the association is in the detail. J Am Coll Cardiol. 2006;47(2):368-9.

2. Castro Hevia J, Antzelevitch C, Tornés Bárzaga F, Dorantes Sánchez M, Dorticós Balea F, Zayas Mo-lina R, et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventri-cular fibrillation in patients with the Brugada syn-drome. J Am Coll Cardiol. 2006;47(9):1828-34.

3. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53(282):457-81.

4. Dorantes M, Castro J, Tornés F, Quiñones MA, Za-yas R, Dorticós F. Muerte súbita por causa eléctrica en sujetos sin enfermedad cardíaca estructural de-mostrable. Experiencia cubana. Arch Cardiol Méx. 2004;74(4):283-9.

5. Tornés FJ, Cisneros P, Dorantes M, Castro J, Zayas R, Quiñones MA, et al. Tormenta eléctrica en pa-cientes con cardioversor-desfibrilador automático implantable. Arch Cardiol Mex. 2008;78(1):68-78.

6. Jordaens LJ, Mekel JM. Electrical storm in the ICD era. Europace. 2005;7(2):181-3.

7. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implica-tions. J Am Coll Cardiol. 1998;32(7):1909-15.

8. Freedberg NA, Hill JN, Fogel RI, Prystowsky EN. Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibri-llator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. J Am Coll Cardiol. 2001;37(7):1910-5.

9. Sánchez JM, Katsiyiannis WT, Gage BF, Chen J, Fad-dis MN, Gleva MJ, et al. Implantable cardioverter-defibrillator therapy improves long-term survival in patients with unexplained syncope, cardiomyopa-thy, and a negative electrophysiologic study. Heart Rhythm. 2005;2(4):367-73.

10. 10.Healy E, Goyal S, Browning C, Robotis D, Ramaswa-my K, Rofino-Nadoworny K, et al. Inappropriate ICD therapy due to proarrhythmic ICD shocks and hy-perpolarization. Pacing Clin Electrophysiol. 2004; 27(3):415-6.

11. 11.Morita H, Kusano KF, Miura D, Nagase S, Nakamura K, Morita ST, et al. Fragmented QRS as a marker of conduction abnormality and a predictor of progno-sis of Brugada syndrome. Circulation. 2008;118(17): 1697-704.

12. 12.Das MK, Zipes DP. Fragmented QRS: a predictor of mortality and sudden cardiac death. Heart Rhythm. 2009;6(3 Suppl):S8-14.

13. 13.Viitasalo M, Oikarinen L, Swan H, Väänänen H, Glat-ter K, Laitinen PJ, et al. Ambulatory electrocardio-graphic evidence of transmural dispersion of repo-larization in patients with long-QT syndrome type 1 and 2. Circulation. 2002;106(19):2473-8.

14. 14.Yan GX, Antzelevitch C. Cellular basis for the elec-trocardiographic J wave. Circulation. 1996;93(2): 372-9.

15. 15.Wellens HJ. Early repolarization revisited. N Engl J Med. 2008;358(19):2063-5.

16. 16.Rosso R, Kogan E, Belhassen B, Rozovski U, Schein-man MM, Zeltser D, et al. J-point elevation in survi-vors of primary ventricular fibrillation and matched control subjects. Incidence and clinical significance. J Am Coll Cardiol. 2008;52(15):1231-8.

17. 17.Buja G, Miorelli M, Turrini P, Melacini P, Nava A. Comparison of QT dispersion in hypertrophic car-

18. diomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol. 1993;72(12):973-6.

19. 18.Shah RR. Drug-induced QT dispersion: does it pre-dict the risk of torsade de pointes? J Electrocardiol. 2005;38(1):10-8.

20. 19.Gadaleta FL, Llois SC, Sinisi VA, Quiles J, Avanzas P, Kaski JC. Prolongación del intervalo QT corregido: nuevo predictor de riesgo cardiovascular en el sín-drome coronario agudo sin elevación del ST. Rev Esp Cardiol. 2008;61(6):572-8.

21. 20.Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improve survival with an implant-ed defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335(26):1933-40.

22. 21.Aiba T, Shimizu W, Inagaki M, Satomi K, Taguchi A, Kurita T, et al. Excessive increase in QT interval and dispersion of repolarization predict recurrent ven-tricular tachyarrhythmia after amiodarone. Pacing Clin Electrophysiol. 2004;27(7):901-9.

23. 22.Malik M, Batchvarov VN. Measurement, inter-pretation and clinical potential of QT dispersion. J Am Coll Cardiol. 2000;36(6):1749-66.

24. 23.Perkiömäki JS, Koistinen MJ, Yli-Mäyry S, Huikuri HV. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhyth-mias after previous myocardial infarction. J Am Coll Cardiol. 1995;26(1):174-9.

25. 24.Mirvis DM. Spatial variation of QT intervals in nor-mal persons and patients with acute myocardial in-farction. J Am Coll Cardiol. 1985;5(3):625-31.

26. 25.Kelly RF, Parillo JE, Hollenberg SM. Effect of corona-ry angioplasty on QT dispersion. Am Heart J. 1997; 134(3):399-405.

27. 26.Yamaguchi M, Shimizu M, Ino H, Terai H, Uchiyama K, Oe K, et al. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new in-dex for arrhythmogenicity. Clin Sci (Lond). 2003; 105(6):671-6.

28. 27.Antzelevitch C. T peak-Tend interval as an index of transmural dispersion of repolarization. Eur J Clin Invest. 2001;31(7):555-7.

29. 28.Kors JA, Ritsema van Eck HJ, van Herpen G. The meaning of the Tp-Te interval and its diagnostic value. J Electrocardiol. 2008;41(6):575-80.

30. 29.Desai AD, Yaw TS, Yamazaki T, Kaykha A, Chun S, Froelicher VF. Prognostic significance of quan-titative QRS duration. Am J Med. 2006;119(7):600-6.

31. 30.Shamim W, Yousufuddin M, Cicoria M, Gibson DG, Coats AJ, Henein MY. Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart. 2002;

32. 88(1):47-51.

33. 31.Kardys I, Kors JA, van der Meer IM, Hofman A, van der Kuip DA, Witteman JC. Spatial QRS-T angle pre-dicts cardiac death in a general population. Eur Heart J. 2003;24(14):1357-64.